Mesenchymal stem/stromal cells
Iberian pig mesenchymal stem/stromal cells from dermal skin, abdominal and subcutaneous adipose tissues, and peripheral blood: in vitro characterization and migratory properties in inflammation
... of stem cells including porcine MSCs from umbilical cord [39] and from skin ...of cells expressing alka- line phosphatase activity is not always uniform, varying according to the tissue source ...
13
Perinatal sources of mesenchymal stem cells: Wharton’s jelly, amnion and chorion
... villous mesenchymal stem/stromal cells to ...of mesenchymal cells of the first trimester and of a term placenta showed no significant differences between early and late ...
22
Human endometrial mesenchymal stem cells restore ovarian function through improving the renewal of germline stem cells in a mouse model of premature ovarian failure
... novel stem cell source has the superiority to conventional ...mal stem cells (EnSCs) with mesenchymal stem/stromal cells (MSCs) characteristics have been isolated from ...
13
Functional similarities of microRNAs across different types of tissue stem cells in aging
... tissue stem cells (TSCs) contribute to loss of tissue homeostasis, including re- ductions in lymphopoiesis and the long-term repopu- lating abilities of hematopoietic stem/progenitor cells ...
5
Adipose-derived stromal cells in regulation of hematopoiesis
... These cells were ex- tracted from diverse anatomical sites, such as superficial abdominal areas, the upper arm, and inguinal and trochanteric areas [9, ...to cells isolated from adipose tissue in different ...
11
Quantification of Mesenchymal Stem Cells (MSCs) at Sites of Human Prostate Cancer
... immunomodulatory cells, including BM-MSCs, which are recruited to prostate cancer lesions ...these cells in the prostate during tissue regrowth [54], carcinogenesis (Figure 3, Table 2), and ...
12
Mesenchymal stem cells in arthritic diseases
... T cells stimulate monocytes, macrophages, and FLSs to produce inflammatory mediators, including IL-1, TNF- α , IFN- γ , and IL-6, and secrete MMPs, leading to the systemic inflammation that eventually results in ...
12
Understanding the regulatory mechanisms of endometrial cells on activities of endometrial mesenchymal stem-like cells during menstruation
... endometrial stromal cells or eMSCs (8000–10,000 cells) were resuspended in growth medium and transferred to slides coated with 3- aminopropyl-triethoxysilane using a Shadon Cytospin Centrifuge ...
14
Translation of remote control regenerative technologies for bone repair
... Controlled Differentiation of Human Bone Marrow Stromal Cells Using Magnetic Nanoparticle Technology.. Concise Review: The Surface Markers and Identity of Human Mesenchymal Stem Cells.[r] ...
42
Regenerative medicine in the treatment of idiopathic pulmonary fibrosis: current position
... of stem cell therapy, specifically mesenchymal stem cells (MSCs), a multipotent stromal cell population, which have demonstrated promising data in multiple animal models of pulmonary ...
5
Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms
... The cells were prepared from bone marrow aspirates taken from the iliac crest of six ...Nucleated cells were isolated using Ficoll-Paque density gradient (Amersham Pharmacia Biotech, Milwaukee, WI, USA) and ...
17
Mesenchymal stromal cells in the development and therapy of bronchopulmonary dysplasia
... to stem cell antigen-1 (Sca-1)-positive/CD90-negative lung (myo-)fibroblasts, Sca-1 ...II cells (AEC-II) and Clara cells in vitro ...of mesenchymal-epithelial crosstalk in postnatal lung ...
6
Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata
... isolated cells. In fact, the immunophenotyping of the transplanted cells showed clearly a heterogeneous population of freshly isolated cells, which expressed not only the mesenchymal ...
9
Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation
... , transcriptome, clonal develop- ment, and the immune modulatory capacity of MSC-EM after different induction time points. First, we markedly im- proved the transduction of UCPs by targeting the proposed stem cell ...
14
Chondrogenic induction of mesenchymal stromal/stem cells from Wharton’s jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering
... Although numerous studies have shown the successful chondrogenic induction of WJ-MSC in 3D scaffolds, our work demonstrated chondrogenic differentiation of WJ- MSC without adding growth factors. Once seeded in Alg/ HA ...
13
Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol
... investigated stem cells in both acute and chronic ischemia models [24, ...various stem cell types and were restricted to large animal models, whereas our review will focus on MSCs and consider both ...
8
First-in-man intravenous implantation of stromal vascular fraction in psoriasis: a case study
... Background: Stromal vascular fraction (SVF) is a mixture of adipose-derived stem cells/ mesenchymal stem cells, endothelial/progenitors, pericytes, fibroblasts, and other ...
6
Mesenchymal stem cells as therapeutic target of biophysical stimulation for the treatment of musculoskeletal disorders
... The mechanisms of action of ESWT, when applied in non-urological indications, are not related to the direct mechanical effect but to the different pathways of biological reactions that derive from those acoustic ...
8
Stem cells from adipose tissue
... of stem cells, the manipulation of the patient’s own cells, and the use of scaffold materials that trigger biological signals in order to accelerate the regenerative ...of stem cells ...
22
Therapeutic prospects of extracellular vesicles in cancer treatment
... FiGURe 1 | Extracellular vesicle (EV) properties and application in antitumor treatment. (A) EVs can be classified based upon their biogenesis and are divided into exosomes, microvesicles (MVs), and apoptotic bodies ...
10